Abstract
Objectives
The endothelial cell (EC)-selective receptor tyrosine kinase, Tie2, and its ligands angiopoietin Ang-1 and Ang-2, are essential for blood vessel maintenance and repair. Ang-1 is an agonist of Tie2 receptor activation, whereas Ang-2 is a context-dependent antagonist/agonist. Therefore, we investigated the role of the EC-selective phosphatase, human protein tyrosine phosphatase beta (HPTPβ), in regulating Tie2 activity.
Methods and results
siRNA silencing of HPTPβ enhanced Ang-1 and Ang-2-induced Tie2 phosphorylation at 10 min (2.5-fold, P < 0.001; and 1.8-fold, P < 0.05, respectively). The cell survival response to Ang-1, but not Ang-2, was enhanced by HPTPβ silencing as measured by flow cytometry (0.85-fold to 0.66-fold, P < 0.05) and ELISA (0.88-fold to 0.53-fold, P < 0.01). Hypoxia, which upregulated HPTPβ expression in endothelial cells, impaired Ang-1-induced Tie2 phosphorylation.
Conclusions
These results reveal a novel role for HPTPβ in modulating Ang-1-Tie2 signaling and endothelial cell survival.
Similar content being viewed by others
References
Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML (1994) Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8:1897–1909. doi:10.1101/gad.8.16.1897
Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Circ Res 86:24–29
Jones N, Voskas D, Master Z, Sarao R, Jones J, Dumont DJ (2001) Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO Rep 2:438–445
Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM (1999) Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511–2514. doi:10.1126/science.286.5449.2511
Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55–60. doi:10.1126/science.277.5322.55
Teichert-Kuliszewska K, Maisonpierre PC, Jones N, Campbell AI, Master Z, Bendeck MP, Alitalo K, Dumont DJ, Yancopoulos GD, Stewart DJ (2001) Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res 49:659–670. doi:10.1016/S0008-6363(00)00231-5
Harfouche R, Hussain SN (2006) Signaling and regulation of endothelial cell survival by angiopoietin-2. Am J Physiol Heart Circ Physiol 291:H1635–H1645. doi:10.1152/ajpheart.01318.2005
Kim I, Kim JH, Moon SO, Kwak HJ, Kim NG, Koh GY (2000) Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Oncogene 19:4549–4552. doi:10.1038/sj.onc.1203800
Gill KA, Brindle NP (2005) Angiopoietin-2 stimulates migration of endothelial progenitors and their interaction with endothelium. Biochem Biophys Res Commun 336:392–396. doi:10.1016/j.bbrc.2005.08.097
Kim KL, Shin IS, Kim JM, Choi JH, Byun J, Jeon ES, Suh W, Kim DK (2006) Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells. Cardiovasc Res 72:394–402. doi:10.1016/j.cardiores.2006.08.002
Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM (1998) Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273:18514–18521. doi:10.1074/jbc.273.29.18514
Baumer S, Keller L, Holtmann A, Funke R, August B, Gamp A, Wolburg H, Wolburg-Buchholz K, Deutsch U, Vestweber D (2006) Vascular endothelial cell-specific phosphotyrosine phosphatase (VE–PTP) activity is required for blood vessel development. Blood 107:4754–4762. doi:10.1182/blood-2006-01-0141
Fachinger G, Deutsch U, Risau W (1999) Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene 18:5948–5953. doi:10.1038/sj.onc.1202992
Dominguez MG, Hughes VC, Pan L, Simmons M, Daly C, Anderson K, Noguera-Troise I, Murphy AJ, Valenzuela DM, Davis S, Thurston G, Yancopoulos GD, Gale NW (2007) Vascular endothelial tyrosine phosphatase (VE–PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis. Proc Natl Acad Sci USA 104:3243–3248. doi:10.1073/pnas.0611510104
Jones N, Iljin K, Dumont DJ, Alitalo K (2001) Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2:257–267. doi:10.1038/35067005
Huang L, Turck CW, Rao P, Peters KG (1995) GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase. Oncogene 11:2097–2103
Huang L, Sankar S, Lin C, Kontos CD, Schroff AD, Cha EH, Feng SM, Li SF, Yu Z, Van Etten RL, Blanar MA, Peters KG (1999) HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity. J Biol Chem 274:38183–38188. doi:10.1074/jbc.274.53.38183
Krueger NX, Streuli M, Saito H (1990) Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. EMBO J 9:3241–3252
Harder KW, Anderson LL, Duncan AM, Jirik FR (1992) The gene for receptor-like protein tyrosine phosphatase (PTPRB) is assigned to chromosome 12q15-q21. Cytogenet Cell Genet 61:269–270. doi:10.1159/000133419
Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, Moller NP (2001) Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol 21:7117–7136. doi:10.1128/MCB.21.21.7117-7136.2001
Gaits F, Li RY, Ragab A, Ragab-Thomas JM, Chap H (1995) Increase in receptor-like protein tyrosine phosphatase activity and expression level on density-dependent growth arrest of endothelial cells. Biochem J 311(Pt 1):97–103
Gaits F, Li RY, Ragab A, Selves J, Ragab-Thomas JM, Chap H (1994) Implication of a protein-tyrosine-phosphatase in human lung cancer. Cell Mol Biol (Noisy -le-grand) 40:677–685
Kim I, Kim HG, Moon SO, Chae SW, So JN, Koh KN, Ahn BC, Koh GY (2000) Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res 86(9):952–959
Harfouche R, Gratton JP, Yancopoulos GD, Noseda M, Karsan A, Hussain SN (2003) Angiopoietin-1 activates both anti- and proapoptotic mitogen-activated protein kinases. FASEB J 17:1523–1525
Kim YM, Kim KE, Koh GY, Ho YS, Lee KJ (2006) Hydrogen peroxide produced by angiopoietin-1 mediates angiogenesis. Cancer Res 66:6167–6174. doi:10.1158/0008-5472.CAN-05-3640
Chen JX, Zeng H, Lawrence ML, Blackwell TS, Meyrick B (2006) Angiopoietin-1-induced angiogenesis is modulated by endothelial NADPH oxidase. Am J Physiol Heart Circ Physiol 291:H1563–H1572. doi:10.1152/ajpheart.01081.2005
Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D (2002) VE–PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J 21(18):4885–4895. doi:10.1093/emboj/cdf497
Acknowledgement
This study was supported by a grant from the Canadian Institutes of Health Research (82791), a fellowship from the Heart and Stroke Foundation of Canada to P.J., and a Government of Ontario/Heart and Stroke Foundation of Ontario Graduate Scholarship in Science and Technology to O.K.Y.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yacyshyn, O.K., Lai, P.F.H., Forse, K. et al. Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells. Angiogenesis 12, 25–33 (2009). https://doi.org/10.1007/s10456-008-9126-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10456-008-9126-0